Unicycive Therapeutics Inc (UNCY) — Cash Flow Quality Index

Latest as of March 2025: -15.62x

Unicycive Therapeutics Inc (UNCY) has a Cash Flow Quality Index of -15.62x as of March 2025. Operating cash flow of $-8.90 Million is below net income of $570.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Unicycive Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-15.62x

Operating CF / Net Income

Operating Cash Flow

$-8.90 Million

USD

Net Income

$570.00K

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Unicycive Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Unicycive Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.